Skip to main content
SpringerLink
Log in
Book cover

Pancreatic Neuroendocrine Neoplasms pp 1–11Cite as

Historical Background and Epidemiology

  • Chapter

  • 1090 Accesses

Abstract

The discovery of the endocrine pancreas was made in 1869 by Paul Langerhans when he was at the end of his medical studies. He described a cluster of clear cells in a small islet, but he was disappointed not to be able to explain the role of these cells. Their role in diabetes mellitus was suggested later by E. Laguesse and by E.L. Opie. Tumors resembling these cells had been reported a century ago. Since then, different types of pancreatic neuroendocrine tumors (PanNETs) have been described; most of them are not associated with a clinical syndrome (the so-called nonfunctioning PanNETs), while PanNETs that manifest a clinical syndrome (“functioning PanNETs”) take their name from the hormone involved (insulinoma, gastrinoma, glucagonoma, VIPoma, and somatostatinoma). PanNETs represent 1.3–3 % of all pancreatic neoplasms and 7 % of all gastroenteropancreatic neuroendocrine tumors. The incidence differs according to the geographic area, gender, and race as well as between developed countries and undeveloped ones. While the number of exocrine pancreatic tumors diagnosed has remained steady, in the last few years, there has been an increase in the number of PanNETs observed, particularly in older people (>60 years). Now the prevalence of PanNETs accounts for more than 10 % of pancreatic tumors, reflecting the different behavior of the two entities. About 10 % of PanNETs are linked to hereditary syndromes, and, in these cases, the tumors occur at an earlier age.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Fitzgerald PJ (1980) Medical anecdotes concerning some diseases of the pancreas. In: Fitzgerald PJ, Morrison AB (eds) The pancreas. Williams and Wilkins, Baltimore, pp 1–29

    Google Scholar 

  2. Singer C (1957) A short history of anatomy from the Greeks to Harvey. Dover Publications, New York, p 111

    Google Scholar 

  3. Garrison FH (1929) An introduction to the history of medicine. WB Saunders, Philadelphia, pp 554–690

    Google Scholar 

  4. Whipple AO (1960) A historical sketch of the pancreas. In: Howard JM, Jordan GH (eds) Surgical diseases of the pancreas. JB Lippincott, Philadelphia, pp 1–6

    Google Scholar 

  5. Langerhans P (1869) Beiträge zur mikroskopischen anatomie der bauchspeicheldrüse. Berlin Univ, Berlin

    Google Scholar 

  6. Laguesse E (1894) Sur la formation des ilots de Langerhans dans le pancréas. C R Soc Seances Soc Biol Fil Paris 46:819–820

    Google Scholar 

  7. Banting FG, Best CH, Collip JB et al (1922) Pancreatic extracts in the treatment of diabetes mellitus. Can Med Assoc J 12(3):141–146

    CAS  PubMed Central  PubMed  Google Scholar 

  8. Kimball CP, Murlin JR (1923) Aqueous extracts of pancreas: III. Some precipitation reactions of insulin. J Biol Chem 58:337–346

    CAS  Google Scholar 

  9. de Duve C (1951) Hyperglycemic principle of the pancreas (glucagon, H-G factor). Rev Med Liege 6(10):258–263

    PubMed  Google Scholar 

  10. Diamare V (1899) Studi comparativi sulle isole di Langerhans del pancreas. Intern Monatschr für Anat und Physiol 16:155–209

    Google Scholar 

  11. Bensley RR (1911) Studies on the pancreas of the guinea pig. Am J Anat 12:297–388

    Article  Google Scholar 

  12. Bloom W (1931) A new type of granular cell in the islet of Langerhans of man. Anat Rec 49:363–371

    Article  Google Scholar 

  13. Deconinck JF, Potvliege PR, Gepts W (1971) The ultrastructure of the human pancreatic islets. I. The islets of adults. Diabetologia 7(4):266–282

    Article  CAS  PubMed  Google Scholar 

  14. Deconinck JF, Van Assche FA, Potvliege PR et al (1972) The ultrastructure of the human pancreatic islets. II. The islets of neonates. Diabetologia 8(5):326–333

    Article  CAS  PubMed  Google Scholar 

  15. Nicholls AG (1902) Simple adenoma of the pancreas arising from an island of Langerhans. J Med Res 8:385–395

    CAS  PubMed Central  PubMed  Google Scholar 

  16. Wilder RM, Allan FN, Power MH et al (1927) Carcinoma of islands of pancreas: hyperinsulinism and hypoglycemia. JAMA 89:348–355

    Article  CAS  Google Scholar 

  17. Whipple AO (1938) The surgical therapy of hyperinsulinism. J Int Chir 3:237–276

    Google Scholar 

  18. Zollinger RM, Ellison EH (1955) Primary peptic ulcerations of the jejunum associated with islet cell tumors of the pancreas. Ann Surg 142:709–728

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  19. Gregory RA, Tracy HJ, French JM et al (1960) Extraction of a gastrin-like substance from a pancreatic tumour in a case of Zollinger-Ellison syndrome. Lancet I:1045–1048

    Article  Google Scholar 

  20. Underdahl LO, Woolner LB, Black BM (1953) Multiple endocrine adenomas; report of 8 cases in which the parathyroids, pituitary and pancreatic islets were involved. J Clin Endocrinol Metab 13(1):20–47

    Article  CAS  PubMed  Google Scholar 

  21. Moldawer MP, Nardi GL, Raker JW (1954) Concomitance of multiple adenomas of the parathyroids and pancreatic islets with tumor of the pituitary: a syndrome with a familial incidence. Am J Med Sci 228(2):190–206

    Article  CAS  PubMed  Google Scholar 

  22. Laidlaw GF (1938) Nesidioblastoma, the islet tumor of the pancreas. Am J Pathol 14(2):125–134

    CAS  PubMed Central  PubMed  Google Scholar 

  23. Weichert RF, Roth LM, Krementz ET et al (1971) Carcinoid-islet cell tumors of the duodenum. Report of twenty-one cases. Am J Surg 121(2):195–205

    Article  PubMed  Google Scholar 

  24. Oberndorfer S (1907) Carcinoid tumors of the small intestine. Frankf Z Pathol 1:426–432

    Google Scholar 

  25. Szijj I, Csapó Z, László FA et al (1969) Medullary cancer of the thyroid gland associated with hypercorticism. Cancer 24(1):167–173

    Article  CAS  PubMed  Google Scholar 

  26. Solcia E, Klöppel G, Sobin SH (eds) (2000) Histological typing of endocrine tumours. Springer, Berlin

    Google Scholar 

  27. DeLellis R, Lloyd RV, Heitz PU et al (2004) WHO classification of tumours; pathology and genetics; tumors of endocrine organs. IARC Press, Lyon, pp 177–208

    Google Scholar 

  28. Bosman FT, Carneiro F, Hruban RH et al (2010) WHO classification of tumors of the digestive system. IARC Press, Lyon, pp 13–14, 322–326

    Google Scholar 

  29. Jones S, Zhang X, Parsons DW et al (2008) Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321(5897):1801–1806

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  30. Jiao Y, Shi C, Edil BH et al (2011) DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors. Science 331:1199–1203

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  31. Yao JC, Hassan M, Phan A et al (2008) One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 26(18):3063–3072

    Article  PubMed  Google Scholar 

  32. Lawrence B, Gustafsson BI, Chan A et al (2011) The epidemiology of gastroenteropancreatic neuroendocrine tumors. Endocrinol Metab Clin North Am 40(1):1–18

    Article  PubMed  Google Scholar 

  33. Zhou J, Enewold L, Stojadinovic A et al (2010) Incidence rates of exocrine and endocrine pancreatic cancers in the United States. Cancer Causes Control 21(6):853–861

    Article  PubMed  Google Scholar 

  34. Lahat G, Ben Haim M, Nachmany I et al (2009) Pancreatic incidentalomas: high rate of potentially malignant tumors. J Am Coll Surg 209(3):313–319

    Article  PubMed  Google Scholar 

  35. Crippa S, Partelli S, Zamboni G et al (2014) Incidental diagnosis as prognostic factor in different tumor stages of nonfunctioning pancreatic endocrine tumors. Surgery 155(1):145–153

    Article  PubMed  Google Scholar 

  36. Korpàssy B (1939) Die Basalzellenmetaplasie des Ausfűhrungsgänge des Pankreas. Virchows Archiv A Pathol Pathol Anat 303:359–373

    Article  Google Scholar 

  37. Frantz VK (1959) Tumors of the pancreas. In: Atlas of tumor pathology. Armed Forces Institute of Pathology, Washington, DC, pp 79–149

    Google Scholar 

  38. Warren S, Le Compte PM, Legg MA (1966) The pathology of diabetes mellitus. Lea & Febiger, Philadelphia

    Google Scholar 

  39. Becker V (1971) Pathologicoanatomical aspects of tumors with endocrine activity. Langenbecks Arch Surg 329:426–437

    Article  CAS  Google Scholar 

  40. Grimelius L, Hultquist GT, Stenkvist B (1975) Cytological differentiation of asymptomatic pancreatic islet cell tumours in autopsy material. Virchows Arch Pathol Anat Physiol Klin Med 365:275–288

    Article  CAS  Google Scholar 

  41. Kimura W, Kuroda A, Morioka Y (1991) Clinical pathology of endocrine tumors of the pancreas. Analysis of autopsy cases. Dig Dis Sci 36:933–942

    Article  CAS  PubMed  Google Scholar 

  42. Lam KY, Lo CY (1997) Pancreatic endocrine tumour: a 22-year clinico-pathological experience with morphological, immunohistochemical observation and a review of the literature. Eur J Surg Oncol 23:36–42

    Article  CAS  PubMed  Google Scholar 

  43. Kishi S, Sakamoto K, Mori M et al (2012) Asymptomatic insulinoma: a case report and autopsy series. Diabetes Res Clin Pract 98(3):445–451

    Article  PubMed  Google Scholar 

  44. Buchanan KD, Johnston CF, O’Hare MM et al (1986) Neuroendocrine tumors. A European view. Am J Med 81:14–22

    Article  CAS  PubMed  Google Scholar 

  45. Eriksson B, Öberg K, Skogseid B (1989) Neuroendocrine pancreatic tumors. Clinical findings in a prospective study of 84 patients. Acta Oncol 28:373–377

    Article  CAS  PubMed  Google Scholar 

  46. Watson RG, Johnston CF, O’Hare MM et al (1989) The frequency of gastrointestinal endocrine tumours in a well-defined population – Northern Ireland 1970–1985. Q J Med 72:647–657

    CAS  PubMed  Google Scholar 

  47. Carriaga MT, Henson DE (1995) Liver, gallbladder, extrahepatic bile ducts, and pancreas. Cancer 75:171–190

    Article  CAS  PubMed  Google Scholar 

  48. Lepage C, Bouvier AM, Phelip JM et al (2004) Incidence and management of malignant digestive endocrine tumours in a well defined French population. Gut 53:549–553

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  49. Halfdanarson TR, Rubin J, Farnell MB et al (2008) Pancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic endocrine tumors. Endocr Relat Cancer 15(2):409–427

    Article  PubMed Central  PubMed  Google Scholar 

  50. Ito T, Sasano H, Tanaka M et al (2010) Epidemiological study of gastroenteropancreatic neuroendocrine tumors in Japan. J Gastroenterol 45(2):234–243

    Article  PubMed  Google Scholar 

  51. Garcia-Carbonero R, Capdevila J, Crespo-Herrero G (2010) Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE). Ann Oncol 21(9):1794–1803

    Article  CAS  PubMed  Google Scholar 

  52. Scherübl H, Streller B, Stabenow R et al (2013) Clinically detected gastroenteropancreatic neuroendocrine tumors are on the rise: epidemiological changes in Germany. World J Gastroenterol 19(47):9012–9019

    Article  PubMed Central  PubMed  Google Scholar 

  53. O’Connor JM, Marmissolle F, Bestani C et al (2014) Observational study of patients with gastroenteropancreatic and bronchial neuroendocrine tumors in Argentina: results from the large database of a multidisciplinary group clinical multicenter study. Mol Clin Oncol 2(5):673–684

    PubMed Central  PubMed  Google Scholar 

  54. Ito T, Igarashi H, Nakamura K et al (2014) Epidemiological trends of pancreatic and gastrointestinal neuroendocrine tumors in Japan: a nationwide survey analysis. J Gastroenterol 50(1):58–64

    Google Scholar 

  55. Tsai HJ, Wu CC, Tsai CR et al (2013) The epidemiology of neuroendocrine tumors in Taiwan: a nation-wide cancer registry-based study. PLoS One 8(4):e62487

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  56. Niederle MB, Hackl M, Kaserer K et al (2010) Gastroenteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European Neuroendocrine Tumour Society classification: an analysis based on prospectively collected parameters. Endocr Relat Cancer 17(4):909–918

    Article  PubMed  Google Scholar 

  57. Hauso O, Gustafsson BI, Kidd M et al (2008) Neuroendocrine tumor epidemiology: contrasting Norway and North America. Cancer 113(10):2655–2664

    Article  PubMed  Google Scholar 

  58. Lepage C, Rachet B, Coleman MP (2007) Survival from malignant digestive endocrine tumors in England and Wales: a population-based study. Gastroenterology 132(3):899–904

    Article  PubMed  Google Scholar 

  59. Kuo EJ, Salem RR (2013) Population-level analysis of pancreatic neuroendocrine tumors 2 cm or less in size. Ann Surg Oncol 20(9):2815–2821

    Article  PubMed  Google Scholar 

  60. Halfdanarson TR, Rabe KG, Rubin J et al (2008) Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival. Ann Oncol 19(10):1727–1733

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  61. Jacobsen O, Bardram L, Rehfeld JF (1986) The requirement for gastrin measurements. Scand J Clin Lab Invest 46:423–426

    Article  CAS  PubMed  Google Scholar 

  62. Cullen RM, Ong CE (1987) Insulinoma in Auckland 1970–1985. N Z Med J 100:560–562

    CAS  PubMed  Google Scholar 

  63. Service FJ, McMahon MM, O’Brien PC et al (1991) Functioning insulinoma – incidence, recurrence, and long-term survival of patients: a 60-year study. Mayo Clin Proc 66:711–719

    Article  CAS  PubMed  Google Scholar 

  64. Stamm B, Hacki WH, Klöppel et al (1991) Gastrin-producing tumors and the Zollinger-Ellison syndrome. In: Dayal EY (ed) Endocrine pathology of the gut and pancreas. CRC Press, Boca Raton, pp 155–194

    Google Scholar 

  65. Rindi G, Falconi M, Klersy C et al (2012) TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study. J Natl Cancer Inst 104(10):764–777

    Article  CAS  PubMed  Google Scholar 

  66. Soga J, Yakuwa Y (1994) Pancreatic endocrinomas: a statistical analysis of 1857 cases. J Hepatobiliary Pancreat Surg 1:522–529

    Article  Google Scholar 

  67. Öberg K, Eriksson B (2005) Endocrine tumours of the pancreas. Best Pract Res Clin Gastroenterol 19:753–781

    Article  PubMed  Google Scholar 

  68. Soga J, Yakuwa Y (1998) The gastrinoma/Zollinger-Ellison syndrome: statistical evaluation of a Japanese series of 359 cases. J Hepatobiliary Pancreat Surg 5:77–85

    Article  CAS  PubMed  Google Scholar 

  69. Norton JA, Fraker DL, Alexander HR et al (1999) Surgery to cure the Zollinger-Ellison syndrome. N Engl J Med 341:635–644

    Article  CAS  PubMed  Google Scholar 

  70. Roy PK, Venzon DJ, Shojamanesh H et al (2000) Zollinger-Ellison syndrome. Clinical presentation in 261 patients. Medicine 79:379–411

    Article  CAS  PubMed  Google Scholar 

  71. Weber HC, Venzon DJ, Lin JT et al (1995) Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome: a prospective long-term study. Gastroenterology 108(6):1637–1649

    Article  CAS  PubMed  Google Scholar 

  72. Kloppel G, Heitz PU (1988) Pancreatic endocrine tumors. Pathol Res Pract 183:155–168

    Article  CAS  PubMed  Google Scholar 

  73. Solcia E, Capella C, Klöppel G (1997) Tumors of the endocrine pancreas. In: Atlas of tumor pathology. Armed Forces Institute of Pathology, Washington, DC, pp 145–209

    Google Scholar 

  74. Harris GJ, Tio F, Cruz AB Jr (1987) Somatostatinoma: a case report and review of the literature. J Surg Oncol 36:8–16

    Article  CAS  PubMed  Google Scholar 

  75. Konomi K, Chijiiwa K, Katsuta T et al (1990) Pancreatic somatostatinoma: a case report and review of the literature. J Surg Oncol 43:259–265

    Article  CAS  PubMed  Google Scholar 

  76. Soga J, Yakuwa Y (1999) Somatostatinoma/inhibitory syndrome: a statistical evaluation of 173 reported cases as compared to other pancreatic endocrinomas. J Exp Clin Cancer Res 18:13–22

    CAS  PubMed  Google Scholar 

  77. Smith SL, Branton SA, Avino AJ et al (1998) Vasoactive intestinal polypeptide secreting islet cell tumors: a 15-year experience and review of the literature. Surgery 124:1050–1055

    Article  CAS  PubMed  Google Scholar 

  78. Soga J, Yakuwa Y (1998) Vipoma/diarrheogenic syndrome: a statistical evaluation of 241 reported cases. J Exp Clin Cancer Res 17:389–400

    CAS  PubMed  Google Scholar 

  79. Peng SY, Li JT, Liu YB et al (2004) Diagnosis and treatment of VIPoma in China: (case report and 31 cases review) diagnosis and treatment of VIPoma. Pancreas 28:93–97

    Article  PubMed  Google Scholar 

  80. Modlin IM, Lye KD, Kidd M (2003) A 5-decade analysis of 13,715 carcinoid tumors. Cancer 97(4):934–959

    Article  PubMed  Google Scholar 

  81. Quaedvlieg PF, Visser O, Lamers CB et al (2001) Epidemiology and survival in patients with carcinoid disease in The Netherlands. An epidemiological study with 2391 patients. Ann Oncol 12(9):1295–1300

    Article  CAS  PubMed  Google Scholar 

  82. La Rosa S, Franzi F, Albarello L et al (2011) Serotonin-producing enterochromaffin cell tumors of the pancreas: clinicopathologic study of 15 cases and comparison with intestinal enterochromaffin cell tumors. Pancreas 40(6):883–895

    Article  PubMed  Google Scholar 

  83. Maragliano R, Vanoli A, Albarello L et al (2015) ACTH-secreting pancreatic neoplasms associated with cushing syndrome: clinicopathologic study of 11 cases and review of the literature. Am J Surg Pathol 39(3):374–382

    Google Scholar 

  84. Schneider R, Waldmann J, Swaid Z et al (2011) Calcitonin-secreting pancreatic endocrine tumors: systematic analysis of a rare tumor entity. Pancreas 40(2):213–221

    Article  CAS  PubMed  Google Scholar 

  85. Stringer MD, Ahmadj O (2009) Famous discoveries by medical students. ANZ J Surg 79:901–908

    Article  PubMed  Google Scholar 

  86. Lefèbvre PJ (2011) Early milestones in glucagon research. Diabetes Obes Metab 13(Suppl 1):1–4

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgical and Morphological Sciences, University of Insubria, Via O. Rossi 9, 21100, Varese, Italy

    Fausto Sessa & Roberta Maragliano

Authors
  1. Fausto Sessa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Roberta Maragliano
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Fausto Sessa .

Editor information

Editors and Affiliations

  1. Department of Pathology, Ospedale di Circolo, Varese, Italy

    Stefano La Rosa

  2. Department of Surgical and Morphological Sciences, University of Insubria, Varese, Italy

    Fausto Sessa

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Sessa, F., Maragliano, R. (2015). Historical Background and Epidemiology. In: La Rosa, S., Sessa, F. (eds) Pancreatic Neuroendocrine Neoplasms. Springer, Cham. https://doi.org/10.1007/978-3-319-17235-4_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-17235-4_1

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-17234-7

  • Online ISBN: 978-3-319-17235-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation